-
Problematic meta-analyses: Bayesian and frequentist perspectives on combining randomized controlled trials and non-randomized studies. BMC Med Res Methodol. 2024 Apr 27; 24(1):99.
Moran JL, Linden A. PMID: 38678213; PMCID: PMC11056075.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Electronic connectivity between hospital pairs: impact on emergency department-related utilization. J Am Med Inform Assoc. 2023 12 22; 31(1):15-23.
Adler-Milstein J, Linden A, Hsia RY, Everson J. PMID: 37846192; PMCID: PMC10746309.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Modelling of intensive care unit (ICU) length of stay as a quality measure: a problematic exercise. BMC Med Res Methodol. 2023 09 14; 23(1):207.
Moran JL, Duke GJ, Santamaria JD, Linden A, Australian & New Zealand Intensive Care Society (ANZICS) Centre for Outcomes & Resource Evaluation (. PMID: 37710162; PMCID: PMC10500937.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Erratum: A comprehensive set of post-estimation measures to enrich interrupted time series analysis. Stata Journal. 2022; 22(1):231-233.
Linden A.
-
Computing the fragility index for randomized trials and meta-analyses using Stata. Stata Journal. 2022; 22(1):77-88.
Linden A.
-
Association of Primary Care Engagement in Value-Based Reform Programs With Health Services Outcomes: Participation and Synergies. JAMA Health Forum. 2022 02; 3(2):e220005.
Adler-Milstein J, Linden A, Hollingsworth JM, Ryan AM. PMID: 35977280; PMCID: PMC8903108.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
A regression-with-residuals method for analyzing causal mediation: The rwrmed package. Stata Journal. 2021; 21(3):559-574.
Linden A, Huber C, Wodtke GT.
-
Longitudinal participation in delivery and payment reform programs among US Primary Care Organizations. Health Serv Res. 2022 02; 57(1):47-55.
Adler-Milstein J, Linden A, Bernstein S, Hollingsworth J, Ryan A. PMID: 33644870; PMCID: PMC8763277.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: The evalue package. Stata Journal. 2020; 20(1):162–175.
Linden A, Mathur MB, VanderWeele TJ.
-
Implementing ODA from Within Stata: Implementing CTA from Within Stata: Minimizing Imbalances on Patient Characteristics Between Treatment Groups in Randomized Trials (Invited). Optimal Data Analysis. 2020; 9:89-93.
Linden A.
-
Implementing ODA from Within Stata: Identifying Causal Mechanisms in Interventions (Invited). Optimal Data Analysis. 2020; 9:84-88.
Linden A.
-
Implementing ODA from Within Stata: Modeling Time‐to‐Event (Survival) Data (Invited). Optimal Data Analysis. 2020; 9:79-83.
Linden A.
-
Implementing ODA from Within Stata: Finding the Optimal Cut-Point of a Diagnostic Test or Index (Invited). Optimal Data Analysis. 2020; 9:74-78.
Linden A.
-
Implementing CTA from Within Stata: Using CTA to Generate Propensity Score Weights (Invited). Optimal Data Analysis. 2020; 9:68-73.
Linden A.
-
Implementing CTA from Within Stata: Characterizing Participation in Observational Studies (Invited). Optimal Data Analysis. 2020; 9:63-67.
Linden A.
-
Implementing CTA from Within Stata: Assessing the Quality of the Randomization Process in Randomized Controlled Trials (Invited). Optimal Data Analysis. 2020; 9:57-62.
Linden A.
-
Implementing ODA from Within Stata: Identifying Structural Breaks in Single-Group Interrupted Time Series Designs (Invited). Optimal Data Analysis. 2020; 9:51-56.
Linden A.
-
Implementing ODA from Within Stata: Evaluating Treatment Effects in Multiple‐Group Interrupted Time Series Analysis (Invited). Optimal Data Analysis. 2020; 9:45-50.
Linden A.
-
Implementing ODA from Within Stata: Evaluating Treatment Effects for Survival (Time‐to‐Event) Outcomes (Invited). Optimal Data Analysis. 2020; 9:39-44.
Linden A.
-
Implementing ODA from Within Stata: Assessing Covariate Balance in Observational Studies (Invited). Optimal Data Analysis. 2020; 9:33-38.
Linden A.
-
Implementing ODA from Within Stata: An Application to Dose-Response Relationships (Invited). Optimal Data Analysis. 2020; 9:26-32.
Linden A.
-
Implementing ODA from Within Stata: An Application to Estimating Treatment Effects using Observational Data (Invited). 2020;9:14-20. Optimal Data Analysis. 2020; 9:14-20.
Linden A.
-
Implementing ODA from Within Stata: An Application to Data From a Randomized Controlled Trial (Invited). Optimal Data Analysis. 2020; 9:9-13.
Linden A.
-
Assessing medication adherence using Stata. Stata Journal. 2019; 19(4):820-831.
Linden A.
-
Assessment of Self-monitoring of Blood Glucose in Individuals With Type 2 Diabetes Not Using Insulin. JAMA Intern Med. 2019 02 01; 179(2):269-272.
Platt KD, Thompson AN, Lin P, Basu T, Linden A, Fendrick AM. PMID: 30534950; PMCID: PMC6439646.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Optimizing Suboptimal Classification Trees: Matlab® CART Model Predicting Probability of Lower Limb Prosthesis User’s Functional Potential. Optimal Data Analysis. 2019; 8:84-93.
Yarnold PR, Linden A.
-
Effect of Sample Size on Discovery of Relationships in Random Data by Classification Algorithms. Optimal Data Analysis. 2019; 8:76-80.
Linden A, Yarnold PR.
-
Novometric stepwise CTA analysis discriminating three class Categories using two ordered attributes. Optimal Data Analysis. 2019; 8:68-71.
Yarnold PR, Linden A.
-
Some machine learning algorithms find relationships between variables when none exist -- CTA doesn’t. Optimal Data Analysis. 2019; 8:64-67.
Linden A, Yarnold PR.
-
Logistic Discriminant Analysis and Structural Equation Modeling Both Identify Effects in Random Data. Optimal Data Analysis. 2019; 8:97-102.
Linden A, Bryant FB, Yarnold PR.
-
Multi-layer perceptron neural net model identifies effect in random data. Optimal Data Analysis. 2019; 8:94-96.
Linden A, Yarnold PR.
-
Now trending: Coping with non-parallel trends in difference-in-differences analysis. Stat Methods Med Res. 2019 12; 28(12):3697-3711.
Ryan AM, Kontopantelis E, Linden A, Burgess JF. PMID: 30474484.
View in:
PubMed Mentions:
24 Fields:
Translation:
Humans
-
Practice strategies to improve primary care for chronic disease patients under a pay-for-value program. Healthc (Amst). 2019 Mar; 7(1):30-37.
Cross DA, Nong P, Harris-Lemak C, Cohen GR, Linden A, Adler-Milstein J. PMID: 30197304.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Using randomization tests to assess treatment effects in multiple-group interrupted time series analysis. J Eval Clin Pract. 2019 Feb; 25(1):5-10.
Linden A. PMID: 30003627.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Using machine learning to evaluate treatment effects in multiple-group interrupted time series analysis. J Eval Clin Pract. 2018 08; 24(4):740-744.
Linden A, Yarnold PR. PMID: 29888469.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Using forecast modelling to evaluate treatment effects in single-group interrupted time series analysis. J Eval Clin Pract. 2018 08; 24(4):695-700.
Linden A. PMID: 29749091.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Using group-based trajectory modelling to enhance causal inference in interrupted time series analysis. J Eval Clin Pract. 2018 06; 24(3):502-507.
Linden A. PMID: 29658192.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Using permutation tests to enhance causal inference in interrupted time series analysis. J Eval Clin Pract. 2018 06; 24(3):496-501.
Linden A. PMID: 29460383.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Combining synthetic controls and interrupted time series analysis to improve causal inference in program evaluation. J Eval Clin Pract. 2018 04; 24(2):447-453.
Linden A. PMID: 29356225.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
The Australian gun buy-back program and the rate of suicide by firearm. Optimal Data Analysis. 2018; 7:28-35.
Linden A, Yarnold PR.
-
Using ODA in the evaluation of randomized controlled trials. Optimal Data Analysis. 2018; 7:46-49.
Linden A, Yarnold PR.
-
Using ODA in the evaluation of randomized controlled trials: application to survival outcomes. Optimal Data Analysis. 2018; 7:50-53.
Linden A, Yarnold PR.
-
Reanalysis of the National Supported Work Experiment Using ODA. Optimal Data Analysis. 2018; 7:54-58.
Linden A, Yarnold PR.
-
Identifying maximum-accuracy cut-points for diagnostic indexes via ODA. Optimal Data Analysis. 2018; 7:59-65.
Linden A, Yarnold PR.
-
Comparative accuracy of a diagnostic index modeled using (optimized) regression vs. novometrics. Optimal Data Analysis. 2018; 7:66-71.
Linden A, Yarnold PR.
-
Review of “A Course in Item Response Theory and Modeling with Stata” by Raykov and Marcoulides. Stata Journal. 2018; 18:485-488.
Linden A.
-
A matching framework to improve causal inference in interrupted time-series analysis. J Eval Clin Pract. 2018 04; 24(2):408-415.
Linden A. PMID: 29266646.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
Estimating causal effects for survival (time-to-event) outcomes by combining classification tree analysis and propensity score weighting. J Eval Clin Pract. 2018 04; 24(2):380-387.
Linden A, Yarnold PR. PMID: 29230910.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Identifying causal mechanisms in health care interventions using classification tree analysis. J Eval Clin Pract. 2018 04; 24(2):353-361.
Linden A, Yarnold PR. PMID: 29105259.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Precommitting to choose wisely about low-value services: a stepped wedge cluster randomised trial. BMJ Qual Saf. 2018 05; 27(5):355-364.
Kullgren JT, Krupka E, Schachter A, Linden A, Miller J, Acharya Y, Alford J, Duffy R, Adler-Milstein J. PMID: 29066616.
View in:
PubMed Mentions:
22 Fields:
Translation:
Humans
-
Minimizing imbalances on patient characteristics between treatment groups in randomized trials using classification tree analysis. J Eval Clin Pract. 2017 Dec; 23(6):1309-1315.
Linden A, Yarnold PR. PMID: 28675602.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Modeling time-to-event (survival) data using classification tree analysis. J Eval Clin Pract. 2017 Dec; 23(6):1299-1308.
Linden A, Yarnold PR. PMID: 28670833.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
Using classification tree analysis to generate propensity score weights. J Eval Clin Pract. 2017 Aug; 23(4):703-712.
Linden A, Yarnold PR. PMID: 28371206.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting. J Eval Clin Pract. 2017 Aug; 23(4):697-702.
Linden A. PMID: 28116816.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
A comparison of approaches for stratifying on the propensity score to reduce bias. J Eval Clin Pract. 2017 Aug; 23(4):690-696.
Linden A. PMID: 28074629.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
A comprehensive set of post-estimation measures to enrich interrupted time series analysis. Stata Journal. 2017; 17(1):73–88.
Linden A.
-
Computing propensity score weights for CTA models involving perfectly predicted endpoints. Optimal Data Analysis. 2017; 6:43-46.
Yarnold PR, Linden A.
-
Persistent threats to validity in single-group interrupted time series analysis with a cross over design. J Eval Clin Pract. 2017 Apr; 23(2):419-425.
Linden A. PMID: 27804216.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Challenges to validity in single-group interrupted time series analysis. J Eval Clin Pract. 2017 Apr; 23(2):413-418.
Linden A. PMID: 27630090.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
Combining machine learning and propensity score weighting to estimate causal effects in multivalued treatments. J Eval Clin Pract. 2016 Dec; 22(6):871-881.
Linden A, Yarnold PR. PMID: 27421786.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Combining machine learning and matching techniques to improve causal inference in program evaluation. J Eval Clin Pract. 2016 Dec; 22(6):864-870.
Linden A, Yarnold PR. PMID: 27353301.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Using machine learning to model dose-response relationships. J Eval Clin Pract. 2016 Dec; 22(6):856-863.
Linden A, Yarnold PR, Nallamothu BK. PMID: 27240883.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Using machine learning to identify structural breaks in single-group interrupted time series designs. J Eval Clin Pract. 2016 Dec; 22(6):851-855.
Linden A, Yarnold PR. PMID: 27091355.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Using machine learning to assess covariate balance in matching studies. J Eval Clin Pract. 2016 Dec; 22(6):844-850.
Linden A, Yarnold PR. PMID: 27004916.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Using data mining techniques to characterize participation in observational studies. J Eval Clin Pract. 2016 Dec; 22(6):835-843.
Linden A, Yarnold PR. PMID: 26805004.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Using machine learning to model dose-response relationships via ODA: eliminating response variable baseline variation by ipsative standardization. Optimal Data Analysis. 2016; 5:41-52.
Yarnold PR, Linden A.
-
Review of “Maximizing Predictive Accuracy By P. R. Yarnold R. C. Soltysik. ODA Books, Chicago, IL, 2016, $98.00, 396 pp. ISBN 0 692 70092 7”. J Eval Clin Pract. 2016; 22:835-838.
Linden A.
-
Novometric analysis with ordered class variables: The optimal alternative to linear regression analysis. Optimal Data Analysis. 2016; 22:65-73.
Yarnold PR, Linden A.
-
Theoretical aspects of the D statistic. Optimal Data Analysis. 2016; 22:171-174.
Yarnold PR, Linden A.
-
Estimating Measurement Error of the Patient Activation Measure for Respondents with Partially Missing Data. Biomed Res Int. 2015; 2015:270168.
Linden A. PMID: 26636096; PMCID: PMC4655275.
View in:
PubMed Mentions:
3 Fields:
-
Estimating causal effects for multivalued treatments: a comparison of approaches. Stat Med. 2016 Feb 20; 35(4):534-52.
Linden A, Uysal SD, Ryan A, Adams JL. PMID: 26482211.
View in:
PubMed Mentions:
16 Fields:
Translation:
Humans
-
Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata Journal. 2015; 15(2):480-500.
Linden A.
-
Graphical displays for assessing covariate balance in matching studies. J Eval Clin Pract. 2015 Apr; 21(2):242-7.
Linden A. PMID: 25545944.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
A comprehensive hospital-based intervention to reduce readmissions for chronically ill patients: a randomized controlled trial. Am J Manag Care. 2014 Oct; 20(10):783-92.
Linden A, Butterworth S. PMID: 25365681.
View in:
PubMed Mentions:
22 Fields:
Translation:
Humans
-
Combining propensity score-based stratification and weighting to improve causal inference in the evaluation of health care interventions. J Eval Clin Pract. 2014 Dec; 20(6):1065-71.
Linden A. PMID: 25266868.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
Review of “An Introduction to Stata for Health Researchers, Fourth Edition, by Juul and Frydenberg.”. Stata Journal. 2014; 14(3):697-700.
Linden A.
-
Assessing regression to the mean effects in health care initiatives. BMC Med Res Methodol. 2013 Sep 28; 13:119.
Linden A. PMID: 24073634; PMCID: PMC3849564.
View in:
PubMed Mentions:
57 Fields:
Translation:
Humans
-
Using balance statistics to determine the optimal number of controls in matching studies. J Eval Clin Pract. 2013 Oct; 19(5):968-75.
Linden A, Samuels SJ. PMID: 23910956.
View in:
PubMed Mentions:
47 Fields:
Translation:
Humans
-
Advancing current approaches to disease management evaluation: capitalizing on heterogeneity to understand what works and for whom. BMC Med Res Methodol. 2013 Mar 14; 13:40.
Elissen AM, Adams JL, Spreeuwenberg M, Duimel-Peeters IG, Spreeuwenberg C, Linden A, Vrijhoef HJ. PMID: 23497125; PMCID: PMC3626873.
View in:
PubMed Mentions: Fields:
Translation:
HumansPHPublic Health
-
Using mediation analysis to identify causal mechanisms in disease management interventions. Health Services and Outcomes Research Methodology. 2013; 13:86-108.
Linden A, Karlson KB.
-
Estimating measurement error when annualizing health care costs. J Eval Clin Pract. 2013 Oct; 19(5):933-7.
Linden A, Samuels SJ. PMID: 22844978.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Combining the regression discontinuity design and propensity score-based weighting to improve causal inference in program evaluation. J Eval Clin Pract. 2012 Apr; 18(2):317-25.
Linden A, Adams JL. PMID: 22304484.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Identifying spin in health management evaluations. J Eval Clin Pract. 2011 Dec; 17(6):1223-30.
Linden A. PMID: 21210897.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Use of an algorithm applied to urine drug screening to assess adherence to a hydrocodone regimen. Journal of Clinical Pharmacology & Therapeutics. 2011; 36(2):200-207.
Couto J, Webster L, Romney M, Leider H, Linden A.
-
A successful hospital-based disease management program to reduce admissions among patients with multiple chronic illnesses. International Journal of Person Centered Medicine. 2011; 4(1):675-682.
Linden A, Bonollo M, Fiddes K.
-
Applying a propensity score-based weighting model to interrupted time series data: improving causal inference in programme evaluation. J Eval Clin Pract. 2011 Dec; 17(6):1231-8.
Linden A, Adams JL. PMID: 20973870.
View in:
PubMed Mentions:
63 Fields:
Translation:
Humans
-
Designing a prospective study when randomization is not feasible. Eval Health Prof. 2011 Jun; 34(2):164-80.
Linden A. PMID: 20696741.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Help patients with chronic kidney disease stave off dialysis. J Fam Pract. 2010 Apr; 59(4):212-9.
Linden A, Biuso TJ, Butterworth SW. PMID: 20398579.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Using propensity score-based weighting in the evaluation of health management programme effectiveness. J Eval Clin Pract. 2010 Feb; 16(1):175-9.
Linden A, Adams JL. PMID: 20367829.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Motivational interviewing-based health coaching as a chronic care intervention. J Eval Clin Pract. 2010 Feb; 16(1):166-74.
Linden A, Butterworth SW, Prochaska JO. PMID: 20367828.
View in:
PubMed Mentions:
59 Fields:
Translation:
HumansCTClinical Trials
-
Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data. J Eval Clin Pract. 2010 Feb; 16(1):180-5.
Linden A, Adams JL. PMID: 20367830.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Use of an algorithm applied to urine drug screening to assess adherence to an oxycontin regimen. J Opioid Manag. 2009 Nov-Dec; 5(6):359-64.
Couto JE, Webster L, Romney MC, Leider HL, Linden A. PMID: 20073409.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansPHPublic Health
-
Improving participant selection in disease management programmes: insights gained from propensity score stratification. J Eval Clin Pract. 2008 Oct; 14(5):914-8.
Linden A, Adams JL. PMID: 19018926.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Disease management: truth in advertising. Health Aff (Millwood). 2008 Sep-Oct; 27(5):1482-3; author reply 1483-4.
Linden A. PMID: 18780941.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Narrow model. Health Aff (Millwood). 2008 May-Jun; 27(3):899-900; author reply 900.
Linden A. PMID: 18474995.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Sample size in disease management program evaluation: the challenge of demonstrating a statistically significant reduction in admissions. Dis Manag. 2008 Apr; 11(2):95-101.
Linden A. PMID: 18393649.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Disease management in chronic kidney disease. Adv Chronic Kidney Dis. 2008 Jan; 15(1):19-28.
Rastogi A, Linden A, Nissenson AR. PMID: 18155106.
View in:
PubMed Mentions:
17 Fields:
Translation:
Humans
-
Medicare disease management in policy context. Health Care Financ Rev. 2008; 29(3):1-11.
Linden A, Adler-Milstein J. PMID: 18567239; PMCID: PMC4195041.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
The case-mix of chronic illness hospitalization rates in a managed care population: implications for health management programmes. J Eval Clin Pract. 2007 Dec; 13(6):947-51.
Linden A, Goldberg S. PMID: 18070267.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Evaluation of a medicaid asthma disease management program. Dis Manag. 2007 Oct; 10(5):266-72.
Linden A, Berg GD, Wadhwa S. PMID: 17961079.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Determining if disease management saves money: an introduction to meta-analysis. J Eval Clin Pract. 2007 Jun; 13(3):400-7.
Linden A, Adams JL. PMID: 17518806.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
A conceptual framework for targeting prediabetes with lifestyle, clinical, and behavioral management interventions. Dis Manag. 2007 Feb; 10(1):6-15.
Biuso TJ, Butterworth S, Linden A. PMID: 17309360.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Estimating the effect of regression to the mean in health management programs. Dis Manage Health Outcomes. 2007; 15(1):7-12.
Linden A.
-
Use of the total population approach to measure U.S. disease management industry's cost savings: issues and implications. Dis Manage Health Outcomes. 2007; 15(1):13-18.
Linden A.
-
Health coaching as an intervention in health management programs. Dis Manage Health Outcomes. 2007; 15(5):299-307.
Butterworth S, Linden A, McClay W.
-
Consensus development and application of ICD-9 codes for defining chronic illnesses and their complications. Dis Manage Health Outcomes. 2007; 15(5):315-322.
Linden A, Biuso TJ, Gopal A, Barker AF, Cigarroa J, Haranath SP, Rinkevich D, Stajduhar K.
-
Evaluating program effectiveness using the regression point displacement design. Eval Health Prof. 2006 Dec; 29(4):407-23.
Linden A, Trochim WM, Adams JL. PMID: 17102063.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Is Israel ready for disease management? Isr Med Assoc J. 2006 Oct; 8(10):667-71.
Linden A. PMID: 17125109.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Effect of motivational interviewing-based health coaching on employees' physical and mental health status. J Occup Health Psychol. 2006 Oct; 11(4):358-65.
Butterworth S, Linden A, McClay W, Leo MC. PMID: 17059299.
View in:
PubMed Mentions:
31 Fields:
Translation:
HumansCTClinical Trials
-
What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme. Am J Manag Care. 2006 Apr; 12(4):217-22.
Linden AL. PMID: 16610923.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Evaluating disease management programme effectiveness: an introduction to the regression discontinuity design. J Eval Clin Pract. 2006 Apr; 12(2):124-31.
Linden A, Adams JL, Roberts N. PMID: 16579820.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Disease management interventions II: What else is in the black box? Dis Manag. 2006 Apr; 9(2):73-85.
Linden A, Butterworth SW, Roberts N. PMID: 16620193.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Strengthening the case for disease management effectiveness: un-hiding the hidden bias. J Eval Clin Pract. 2006 Apr; 12(2):140-7.
Linden A, Adams JL, Roberts N. PMID: 16579822.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Evaluating disease management programme effectiveness: an introduction to instrumental variables. J Eval Clin Pract. 2006 Apr; 12(2):148-54.
Linden A, Adams JL. PMID: 16579823.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract. 2006 Apr; 12(2):132-9.
Linden A. PMID: 16579821.
View in:
PubMed Mentions:
150 Fields:
-
In search of financial savings from disease management: Applying the number needed to decrease (NND) analysis to a diabetic population. Dis Manage Health Outcomes. 2006; 4(14):197-202.
Linden A, Biuso TJ.
-
Evaluating the effectiveness of home health as a disease management strategy. Home Health Care Management & Practice. 2006; 3(18):216-222.
Linden A.
-
Using visual displays as a tool to demonstrate disease management program effectiveness. Dis Manag. 2005 Oct; 8(5):301-10.
Linden A, Roberts N. PMID: 16212515.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Letter regarding article by Galbreath et al, "Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure". Circulation. 2005 Jul 05; 112(1):e11; author reply e11.
Linden A, Wilson T. PMID: 15998687.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Potential bias in "controls" used in a heart failure disease-management program. J Am Geriatr Soc. 2005 Jul; 53(7):1268-9.
Wilson T, Linden A. PMID: 16108960.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Financial interests, detailed description of methods, and use of randomized design in a real-world setting. Am J Manag Care. 2005 Jun; 11(6):384; author reply 394.
Wilson T, Linden A. PMID: 15974557.
View in:
PubMed Mentions: Fields:
-
Asthma disease management: regression to the mean or better? Am J Manag Care. 2005 Mar; 11(3):136; author reply 136-7.
Wilson T, Linden A. PMID: 15786850.
View in:
PubMed Mentions: Fields:
Translation:
HumansCTClinical Trials
-
Care management for heart failure. Ann Intern Med. 2005 Mar 01; 142(5):386; author reply 386.
Linden A, Wilson T. PMID: 15738460.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Disease management's economic impact: unproven? Health Aff (Millwood). 2005 Mar-Apr; 24(2):566-7; author reply 567.
Wilson T, Linden A. PMID: 15757944.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A user's guide to the disease management literature: recommendations for reporting and assessing program outcomes. Am J Manag Care. 2005 Feb; 11(2):113-20.
Linden A, Roberts N. PMID: 15726859.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Using propensity scores to construct comparable control groups for disease management program evaluation. Dis Manage Health Outcomes. 2005; 13(2):107-127.
Linden A, Adams J, Roberts N.
-
Evaluating disease management program effectiveness: An introduction to the bootstrap technique. Dis Manage Health Outcomes. 2005; 3(13):159-167.
Linden A, Adams J, Roberts N.
-
Measuring diabetes management. Health Aff (Millwood). 2004 Nov-Dec; 23(6):277-8; author reply 278-9.
Wilson T, Linden A. PMID: 15537618.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Generalizing disease management program results: how to get from here to there. Manag Care Interface. 2004 Jul; 17(7):38-45.
Linden A, Adams JL, Roberts N. PMID: 15341247.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Using an empirical method for establishing clinical outcome targets in disease management programs. Dis Manag. 2004; 7(2):93-101.
Linden A, Adams JL, Roberts N. PMID: 15228794.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Evaluating disease management program effectiveness: an introduction to survival analysis. Dis Manag. 2004; 7(3):180-90.
Linden A, Adams JL, Roberts N. PMID: 15669578.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Disease management interventions: what's in the black box? Dis Manag. 2004; 7(4):275-91.
Linden A, Roberts N. PMID: 15671785.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansPHPublic Health
-
Evaluating disease management program effectiveness adjusting for enrollment (tenure) and seasonality. Research in Health Financial Management. 2004; 9(1):57-68.
Linden A, Adams J, Roberts N.
-
An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manag. 2003; 6(2):93-102.
Linden A, Adams JL, Roberts N. PMID: 14577903.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansPHPublic Health
-
Evaluating disease management program effectiveness: an introduction to time-series analysis. Dis Manag. 2003; 6(4):243-55.
Linden A, Adams JL, Roberts N. PMID: 14736348.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
The complete "how to" guide for selecting a disease management vendor. Dis Manag. 2003; 6(1):21-6.
Linden A, Roberts N, Keck K. PMID: 12899564.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A Risk Adjusted Method of Analysis for Bed-day Reporting at CareAmerica Health Plans. 1997.
Linden A.
-
A physiological comparison of forward vs reverse wheelchair ergometry. Medicine & Science in Sports & Exercise. 1993; 11(25):1265-1268.
Linden A, Holland GJ, Loy SF, Vincent WJ.